The Bioterrorism Act

Two FDA final rules issued in response to the Bioterrorism Response Act of 2002 may significantly affect the supply and importation of pharmaceutical excipients.

External Link - article-81478.pdf

Articles in this issue

over 22 years ago

Article

Coprocessed Excipients for Solid Dosage Forms

over 22 years ago

Article

Manufacturing Execution Systems

over 22 years ago

Article

State-of-the-Art Packaging Machines

over 22 years ago

Article

January 2004

over 22 years ago

Article

Medicare Bill Contains Significant Changes for Drug Manufacturers

over 22 years ago

Article

Establishing and Maintaining an Effective Gas Evaluation and Management Program

over 22 years ago

Article

New Supply-Chain Dynamics

over 22 years ago

Article

In the Spotlight--February 2004

over 22 years ago

Article

January 2004

Get the essential updates shaping the future of pharma manufacturing and compliance. Subscribe to Pharmaceutical Technology and never miss an industry breakthrough.

The Bioterrorism Act

Articles in this issue

Trending on Pharmaceutical Technology

GSK Acquires Nuvalent for $10.6 Billion in Lung Cancer Push

USP Reports Drug Discontinuations on the Rise

Patient Access to Radiopharmaceuticals

Overcoming Fill-Finish Capacity Bottlenecks in Automated Pen Injector Assembly Lines

Why Big Pharma Is Betting Billions on Protein Degraders for Cancer